Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) HKSE
4.11
-0.07(-1.67%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.87B |
| Enterprise Value | 7.63B |
| P/E Ratio | 37.46 |
| PEG Ratio | -0.89 |
| Price/Sales Ratio | 2.24 |
| Price/Book Ratio | 1.17 |
| Enterprise/Revenue | 2.42 |
| Enterprise/EBITDA | 12.97 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.12 |
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 5.48B |
| Revenue/Share | 3.69 |
| Gross Profit | 1.74B |
| EBITDA | 846.59M |
| Net Income | 349.49M |
| Diluted EPS | 0.24 |
Balance Sheet
| Total Cash | 3.5B |
| Total Cash/Share | 2.39 |
| Total Debt | 2.79B |
| Total Debt/Equity | 0.23 |
| Current Ratio | 2.15 |
| Book Value Per Share | 8.33 |
Price History
| 52-Week Change | -15.1 |
| 52-Week High | 7.26 |
| 52-Week Low | 4.01 |
| Moving Average 50 Days | 4.8 |
| Moving Average 200 Days | 5.29 |
Statistics
| Average Volume | 483,300 |
| Shares Outstanding | 3.38B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 2.57 |
| Payout Ratio | 0.12 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
